Literature DB >> 14516179

Factor structure of the Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire evaluated in patients with heartburn predominant reflux disease.

Károly R Kulich1, Ingela Wiklund, Ola Junghard.   

Abstract

AIM: To test whether the original factor structure of the Quality of Life in Reflux and Dyspepsia (QOLRAD) can be replicated in Nordic patients and English speaking patients. PATIENTS AND METHODS: Clinical trial patients with heartburn without esophagitis completed the Swedish, Norwegian, Finnish and Danish versions (n = 634) and the English version (n = 1185). The factor structure was examined using models generated by exploratory and confirmatory factor analysis.
RESULTS: The exploratory factor analysis suggested that the original five-factor structure solution was the most optimal. The Nordic versions explained 67% and the English version 72% of the variance. The factor loading of 22 out of 25 items was >0.55. In the confirmatory factor analysis, because of the sample size, only the Swedish and Norwegian data were used. Confirmatory factor analysis indicated an acceptable goodness of fit of the five-factor solution to the data with a goodness of fit index of 0.85 in the Swedish, 0.77 in the Norwegian and 0.91 in the English speaking population. The internal consistency reliability ranged from 0.70 to 0.94 (in the Nordic translations) and from 0.85 to 0.92 (in the English version), supporting the homogeneity of the items within the factors and thus their construct validity. The QOLRAD distinguished severity and frequency of heartburn, thereby documenting its known-group validity to distinguish between groups of patients.
CONCLUSIONS: The factor structure and dimensionality of the English version and the Swedish and Norwegian translations of the QOLRAD could be replicated by the exploratory and confirmed by the confirmatory factor analysis. The QOLRAD is a valid and reliable instrument for use in clinical trials.

Entities:  

Mesh:

Year:  2003        PMID: 14516179     DOI: 10.1023/a:1025192100450

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  12 in total

1.  Cross-Validation Of Covariance Structures.

Authors:  R Cudeck; M W Browne
Journal:  Multivariate Behav Res       Date:  1983-04-01       Impact factor: 5.923

2.  Recommendations for evaluating the validity of quality of life claims for labeling and promotion.

Authors:  N K Leidy; D A Revicki; B Genesté
Journal:  Value Health       Date:  1999 Mar-Apr       Impact factor: 5.725

3.  The well-being questionnaire: evidence for a three-factor structure with 12 items (W-BQ12).

Authors:  F Pouwer; F J Snoek; H M van der Ploeg; H J Adèr; R J Heine
Journal:  Psychol Med       Date:  2000-03       Impact factor: 7.723

4.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

5.  Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments.

Authors:  N J Talley; S Fullerton; O Junghard; I Wiklund
Journal:  Am J Gastroenterol       Date:  2001-07       Impact factor: 10.864

Review 6.  Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines.

Authors:  F Guillemin; C Bombardier; D Beaton
Journal:  J Clin Epidemiol       Date:  1993-12       Impact factor: 6.437

7.  Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD).

Authors:  I K Wiklund; O Junghard; E Grace; N J Talley; M Kamm; S Veldhuyzen van Zanten; P Paré; N Chiba; D S Leddin; M A Bigard; R Colin; P Schoenfeld
Journal:  Eur J Surg Suppl       Date:  1998

Review 8.  Functional dyspepsia. Current treatment recommendations.

Authors:  Gerald Holtmann; Nicholas J Talley
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

9.  Impact of functional dyspepsia on quality of life.

Authors:  N J Talley; A L Weaver; A R Zinsmeister
Journal:  Dig Dis Sci       Date:  1995-03       Impact factor: 3.199

Review 10.  Epidemiology and natural history of gastro-oesophageal reflux disease.

Authors:  S J Spechler
Journal:  Digestion       Date:  1992       Impact factor: 3.216

View more
  13 in total

Review 1.  Measuring response in the gastrointestinal tract in systemic sclerosis.

Authors:  Dinesh Khanna; Vivek Nagaraja; Heather Gladue; William Chey; Mark Pimentel; Tracy Frech
Journal:  Curr Opin Rheumatol       Date:  2013-11       Impact factor: 5.006

2.  Psychometric validation of the Japanese translation of the Quality of Life in Reflux and Dyspepsia questionnaire in patients with heartburn.

Authors:  Michio Hongo; Yoshikazu Kinoshita; Kojiro Shimozuma; Yuji Kumagai; Mitsutaka Sawada; Masahiro Nii
Journal:  J Gastroenterol       Date:  2007-10-15       Impact factor: 7.527

3.  Psychometric validation of the italian translation of the gastrointestinal symptom-rating scale and quality of life in reflux and dyspepsia questionnaire in patients with gastro-oesophageal reflux disease.

Authors:  Károly R Kulich; Carlo Calabrese; Franco Pacini; Sergio Vigneri; Jonas Carlsson; Ingela K Wiklund
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

4.  Psychometric validation of the Dutch translation of the quality of life in reflux and dyspepsia (QOLRAD) questionnaire in patients with gastroesophageal reflux disease.

Authors:  Leopold G J B Engels; Elly C Klinkenberg-Knol; Jonas Carlsson; Katarina Halling
Journal:  Health Qual Life Outcomes       Date:  2010-08-17       Impact factor: 3.186

5.  Rabeprazole and esomeprazole in mild-to-moderate erosive gastroesophageal reflux disease: A comparative study of efficacy and safety.

Authors:  Rituparna Maiti; Jyothirmai Jaida; P L John Israel; Narendar Koyagura; Sruthi Mukkisa; Anuradha Palani
Journal:  J Pharmacol Pharmacother       Date:  2011-07

6.  The impact of illness in patients with moderate to severe gastro-esophageal reflux disease.

Authors:  Samer El-Dika; Gordon H Guyatt; David Armstrong; Alessio Degl'innocenti; Ingela Wiklund; Carlo A Fallone; Lisa Tanser; Sander Veldhuyzen van Zanten; Diane Heels-Ansdell; Peter Wahlqvist; Naoki Chiba; Alan N Barkun; Peggy Austin; Holger J Schünemann
Journal:  BMC Gastroenterol       Date:  2005-07-10       Impact factor: 3.067

7.  Effects of esomeprazole treatment for gastroesophageal reflux disease on quality of life in 12- to 17-year-old adolescents: an international health outcomes study.

Authors:  Thirumazhisai Gunasekaran; Vasundhara Tolia; Richard B Colletti; Benjamin D Gold; Barry Traxler; Marta Illueca; Joseph A Crawley
Journal:  BMC Gastroenterol       Date:  2009-11-18       Impact factor: 3.067

8.  Reliability and validity of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in dyspepsia: a six-country study.

Authors:  Károly R Kulich; Ahmed Madisch; Franco Pacini; Jose M Piqué; Jaroslaw Regula; Christo J Van Rensburg; László Ujszászy; Jonas Carlsson; Katarina Halling; Ingela K Wiklund
Journal:  Health Qual Life Outcomes       Date:  2008-01-31       Impact factor: 3.186

9.  Validation of a survey methodology for gastroesophageal reflux disease in China.

Authors:  Yang Cao; Xiaoyan Yan; Xiu-Qiang Ma; Rui Wang; Saga Johansson; Mari-Ann Wallander; Jia He
Journal:  BMC Gastroenterol       Date:  2008-08-21       Impact factor: 3.067

10.  Psychometric validation of the German translation of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in patients with reflux disease.

Authors:  Károly R Kulich; Peter Malfertheiner; Ahmed Madisch; Joachim Labenz; Ekkehard Bayerdörffer; Stephan Miehlke; Jonas Carlsson; Ingela K Wiklund
Journal:  Health Qual Life Outcomes       Date:  2003-10-28       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.